Lantern Pharma (LTRN) Q4 2023 Earnings

18MarConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.48
-0.42
-0.35
-0.29

Details

Expected EPS
-0.4
Actual EPS
-0.39
Surprise EPS
0.01
Surprise Percent
+2.5%

Description

Lantern Pharma (LTRN) has reported earnings of -0.39 per share for Q4 2023.

0 Comments

Share your thoughts